Clinical and Translational Science (Sep 2019)

The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies

  • Peter Marks

DOI
https://doi.org/10.1111/cts.12666
Journal volume & issue
Vol. 12, no. 5
pp. 428 – 430

Abstract

Read online

No abstracts available.